Medication Safety LAN Event: May 2017

Topic: Campaign for Meds Management Phase 2 Kick-off: Impact of a Hospital-to-Community Pharmacist Med Management Intervention

Date: Thursday, May 25, 2017

Time: 3:00 – 4:30 PM ET


Audience:

This event was open to beneficiaries, families, healthcare providers, practitioners, partners, and Quality Innovation Network-Quality Improvement Organizations.

Call Summary:

This Medication Safety Learning & Action Network (LAN) Event was on the topic “Campaign for Meds Management Phase 2 Kick-off: Impact of a Hospital-to-Community Pharmacist Med Management Intervention.” This session unveiled Phase 2 of the Campaign for Meds Management (CMM), in addition to featuring Karen Pellegrin, PhD, MBA, who shared information about a unique medication management intervention, the Pharm2Pharm model of care. Pharm2Pharm is a system of medication management services provided by trained hospital and community pharmacists who serve high-risk individuals from hospitalization through transition to home. This model has demonstrated a reduction in medication-related hospitalization rates and a significant return on investment.

Learning Objectives:

  • Understand the value of the Pharm2Pharm (hospital pharmacy to community pharmacy medication management) to patients, providers, and health systems.
  • Identify at least two Pharm2Pharm training and utilization resources.
  • Apply the Pharm2Pharm model of care to alternative high-risk populations.

Slides & Recorded Presentation:

Meet the Speakers:

Anita Thomas, PharmD
Medication Safety Lead
Centers for Medicare & Medicaid Services

Risa Hayes, CPC
Program Specialist
Telligen, QIN NCC

Karen Pellegrin, PhD, MBA
Faculty/Director
University of Hawaii at Hilo

Supplemental Resources:

CE Statement:

Outcome Statement:

The purpose of this session is to prepare healthcare quality improvement professionals to identify and implement effective healthcare strategies by exploring promising practices to achieve individual and community health equity.

We expect that this experience will help participants demonstrate and promote successful delivery of care practices and identify opportunities for improvement, all of which may promote advances in care that impact the Medicare beneficiaries served by the work of the QIO Program.

Method of Participation:

You must participate in the entire activity to receive credit. A statement of credit will be available upon completion of an online evaluation/claimed credit form. The link to the online evaluation will be provided after completion of the activity. If you have questions about this CME/CE activity, please contact AKH Inc. at service@akhcme.com.

CME/CE Credit Provided by AKH Inc., Advancing Knowledge in Healthcare

Physicians:

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare, CRW & Associates and Telligen.  AKH Inc., Advancing Knowledge in Healthcare is accredited by the ACCME to provide continuing medical education for physicians. 

AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants:

NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME.

Pharmacy:

AKH Inc., Advancing Knowledge in Healthcare is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

AKH Inc., Advancing Knowledge in Healthcare approves this knowledge-based activity for 1.5 contact hours (0.15 CEUs). UAN 0077-9999-17-031-L04-P; UAN 0077-9999-17-031-L04-T.  Initial Release Date: 5/25/17

Nursing:

AKH Inc., Advancing Knowledge in Healthcare is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

This activity is awarded 1.5 contact hours.

Nurse Practitioners:

AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider Number: 030803.

This program is accredited for 1.5 contact hours which includes 0 hours of pharmacology.  ID #21718-4.

This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standard

Dietitians:

AKH Inc., Advancing Knowledge in Healthcare is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 1.5 continuing professional education unit (CPEU) for completion of this program/material. CDR Accredited Provider #AN008. The focus of this activity is rated Level 2. Learners may submit evaluations of program/materials quality to the CDR at www.cdrnet.org.

Disclosure of Financial Relationships & Commercial Support:

  • The following planners and faculty do not have any relevant financial relationships to disclose.
  • AKH Inc., CRW & Associates, and Telligen do not have any relevant financial relationships to disclose.
  • No commercial support was received for this activity.

Disclosures:

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by AKH prior to accreditation of the activity and may include any of or combination of the following: attestation to non-commercial content; notification of independent and certified CME/CE expectations; referral to National Author Initiative training; restriction of topic area or content; restriction to discussion of science only; amendment of content to eliminate discussion of device or technique; use of other author for discussion of recommendations; independent review against criteria ensuring evidence support recommendation; moderator review; and peer review.

Disclosure of Unlabeled Use and Investigational Product:

This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer:

This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant's misunderstanding of the content.